Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy

DNA and Cell Biology

Volumn 25, Issue 1, 2006, Pages 25-30

  Li, Zhongming ^a   Song, Dan ^a   Zhang, Hongyong ^b   He, Wei ^a   Fan, Xiaoyong ^a   Zhang, Ying ^a   Huang, Jialu ^a   Wang, Xiaoyi ^a   Liu, Qingliang ^a   Xiong, Sidong ^b  

^a Shanghai H and G Biotechnology Co Inc   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; PROTEIN AG85A; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ACC I GENE; AG85A GENE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GENE; CHIMERA; CONTROLLED STUDY; ELECTROPORATION; ESAT 6 GENE; FEMALE; GENE; GENE INSERTION; HUMORAL IMMUNITY; IMMUNOGENICITY; KPN I GENE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ACYLTRANSFERASES; ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 30644467602     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.25     Document Type: Article

References (25)

1. ANDERSEN, P. (1994). Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
2. BOESEN, H., JENSEN, B.N., WILCKE, T., and ANDERSEN, P. (1995). Human t-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63, 1491-1497.
3. BRANDT, L., ELHAY, M., ROSENKRANDS, I., LINDBLAD, E.B., and ANDERSEN, P. (2000). ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68, 791-795.
4. BRYDER, K., SBAI H., NIELSEN H.V., CORBET, S., NIELSEN, C., WHALEN, R.G., FOMSGAARD, A. (1999). Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg. DNA Cell Biol. 18, 219-225.
5. DANNENBERG, A.M., Jr. (1991). Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12, 228-233.
6. DONNELLY, J.J., ULMER, J.B., SHIVER, J.W., and LIU, M.A. (1997). DNA vaccines. Annu. Rev. Immunol. 15, 617-648.
7. DUPUIS, M., DENIS-MIZE, K., WOO, C., GOLDBECK, C., SELBY, M.J., CHEN, M., OTTEN, G.R., ULMER, J.B., DONNELLY, J.J., OTT, G., MCDONALD, D.M. (2000). Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J. Immunol. 165, 2850-2858.
8. FINE, P.E. (1995). Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 346, 1339-1345.
9. FONSGAAD, A., NIELSEN, H.V., BRYDER, K., NIELSEN, C., MACHUCA, R., BRUUN, L., HANSEN, J., BUUS, S. (1998). Improved humoral and cellular responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Scand. J. Immunol. 47, 289-295.
10. GRONEVIK, E., TOLLEFSEN, S., SIKKELAND, L.I., HAUG, T., TJELLE, T.E., MATHIESEN, I. (2003). DNA transfection of mononuclear cells in muscle tissue. J. Gene Med. 10, 909-917.
11. HUYGEN, K., LOZES, E., GILLES, B., DROWART, A., PALFLIET, K., JURION, F., ROLAND, I., ART, M., DUFAUX, M., NYABENDA, J. (1994). Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 62, 363-370.
12. HUYGEN, K., CONTENT, J., DENNIS, O., MONTGOMERY, D.L., YAWMAN, A.M., DECK, R.R., DEWITT, C.M., ORME, I.M., BALDWIN, S., D'SOUZA, C., et al. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2, 893-898.
13. LANGERMANS, J.A.M., DOHERTY, T.M., VERVENNE, R.A.W., VAN DER LAAN, T., LYASHCHENKO, K., GREENWALD, R., AGGER, E.M., AAGAARD, C., WEILER, H., VAN SOOLINGEN, D., et al. (2005). Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23, 2740-2750.
14. LAUNOIS, P., DELEYS, R., NIANG, M.N., DROWART, A., ANDRIEN, M., DIERCKX, P., CARTEL, J.L., SARTHOU, J.L., VAN VOOREN, J.P., HUYGEN, K. (1994). T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62, 3679-3687.
15. MORRIS, S., KELLY, C., HOWARD, A., and LI, Z. (2000). The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18, 2155-2163.
16. MUSTAFA, A.S., OFTUNG, F., AMOUDY, H.A., MADI, N.M., ABAL, A.T., SHABAN, F., ROSEN KRANDS, I., ANDERSEN, P. (2000). Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines. Clin. Infect. Dis. 30(Suppl 3), S201-5.
17. OLSEN, A.W., WILLIAMS, A., OKKELS, L.M., HATCH, G., ANDERSEN, P. (2004). Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun. 72, 6148-6150.
18. OME, I.M., MCMURRAY, D.N., and BELISLE, J.T. (2001). Tuberculosis vaccine development: Recent progress. Trends Microbiol. 9, 115-118.
19. RAVAIGLIONE, M.C. (2003). The TB epidemic from 1992 to 2002. Tuberculosis 83, 4-14.
20. RAVN P., DEMISSIE, A., EGUALE, T., WONDWOSSON, H., LEIN, D., AMOUDY, H.A., MUSTAFA, A.S., JENSEN, A.K., HOLM, A., ROSEN KRANDS, I., et al. (1999). Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179, 637-645.
21. SCHEERLINCK, J.P.Y., KARLIS, J., TJELLE, T.E., PRESIDENTE, P.J.A., MATHUESEN, I., and NEWTON, S.E. (2004). In vivo electroporation improve immune responses to DNA vaccination in sheep. Vaccine 22, 1820-1825.
22. SMITH, S.M., BROOKES, R., KLEIN, M.R., MALIN, A.S., LUKEY, P.T., KING, A.S., OGG, G.S., HILL, A.V., DOCKRELL, H.M. (2000). Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165, 7088-7095.
23. TANGHE, A., D'SOUZA, S., ROSSEELS, V., DENIS, O., OTTENHOFF, T.H., DALEMANS, W., WHEELER, C., HUYGEN, K. (2001). Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 69, 3041-3047.
24. TIRUVILUAMALA, P., and REICHMAN, L.G. (2002). Tuberculosis. Annu Rev Public Health, 23, 403-426.
25. WIDERA, G., AUSTIN, M., RABUSSAY, D., GOLDBECK, C., BARNETT, S.W., CHEN, M., LEUNG, L., OTTEN, G.R., THUDIUM, K., SELBY, M.J., et al. (2000). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol. 164, 4635-4640.